Precision Oncology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025

Description

Persistence Market Research has recently released a comprehensive report on the global Precision Oncology Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Precision Oncology Market Size (2025E): US$ 132.3 Mn
Projected Market Value (2032F): US$ 280.3 Mn
Global Market Growth Rate (CAGR 2025 to 2032): 10.8%

Precision Oncology Market - Report Scope:

The precision oncology market focuses on targeted cancer therapies based on individual genetic profiles, offering tailored treatments that significantly improve patient outcomes. This approach leverages genomic data, molecular diagnostics, and advanced analytics to identify personalized treatment plans, thereby increasing the efficacy and reducing adverse effects compared to traditional therapies. As the global burden of cancer rises and the demand for customized treatment options grows, precision oncology is gaining substantial traction across the healthcare industry.

Market Growth Drivers:

Several key factors are fueling the growth of the global precision oncology market. The increasing incidence of cancer worldwide is propelling the demand for more effective and personalized treatment solutions. Advances in genomic sequencing, bioinformatics, and molecular diagnostics have significantly enhanced the ability to detect cancer at earlier stages and identify targeted therapy options. Growing investments in cancer research and the rising availability of precision medicine platforms are accelerating market adoption. Additionally, increased collaboration between pharmaceutical companies and research institutions is driving innovation and expanding the pipeline of targeted therapies.

Market Restraints:

Despite its promising outlook, the precision oncology market faces several challenges that could hinder its growth. The high cost of genomic testing and personalized therapies remains a significant barrier, particularly in low- and middle-income countries. Limited access to advanced diagnostic technologies and inadequate healthcare infrastructure in certain regions further restricts market penetration. Regulatory complexities and the time-consuming nature of clinical validation for personalized treatments also pose challenges. Furthermore, concerns regarding data privacy and interoperability among various health IT systems may impact the seamless integration of precision oncology solutions.

Market Opportunities:

The precision oncology market presents significant growth opportunities, driven by ongoing technological advancements and expanding applications across various cancer types. Increasing awareness about the benefits of personalized medicine is encouraging healthcare providers and patients to adopt precision oncology solutions. Emerging markets offer untapped potential due to improving healthcare infrastructure and growing government initiatives to support cancer care. The integration of artificial intelligence and machine learning in diagnostics and treatment planning is expected to revolutionize the field further. Moreover, the development of companion diagnostics and biomarker-based therapies opens new avenues for innovation and market expansion.

Key Questions Answered in the Report:

What are the primary factors driving the global precision oncology market's growth?
Which regions and market segments are experiencing the highest demand for precision oncology solutions?
How are advancements in genomic and molecular diagnostics shaping market dynamics?
Who are the key players in the precision oncology market, and what strategies are they adopting to remain competitive?
What are the emerging trends and future projections for the global precision oncology market?

Competitive Intelligence and Business Strategy:

Leading companies in the global precision oncology market, such as Thermo Fisher Scientific Inc., Diazyme Laboratories, DRG International Inc., Svar Life Science, and Epitope Diagnostics Inc., are investing heavily in R&D to enhance the precision and scope of their oncology solutions. Strategic collaborations with biotech firms and healthcare providers are helping these players accelerate the development and commercialization of targeted therapies. Companies are also focusing on expanding their diagnostic portfolios and increasing geographic reach to capture emerging market opportunities. Emphasis on cost-effective, rapid, and highly accurate testing platforms is becoming a key differentiator in the competitive landscape.

Companies Covered in This Report:

Epitope Diagnostics Inc.
Hycult Biotech
Actim
OPERON
Svar Life Science
BUHLMANN
DRG International Inc.
ALPCO
Diazyme Laboratories
Thermo Fisher Scientific Inc.

Market Segmentation

By Technique:

Enzyme-linked Immunosorbent Assay
Enzyme Fluoroimmunoassay
Immunochromatography
Point-of-care Tests
Others

By Indication:

Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome (IBS)
Colorectal Cancer
Infections
Others

By End-user:

Hospitals & Clinics
Diagnostic Laboratories
Research Institutes
Gastroenterology Centers

By Region:

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

Product Code: PMRREP35389

1. Executive Summary

1.1. Global Precision Oncology Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Regulatory Landscape
3.2. Service Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis

4. Global Precision Oncology Market Outlook:

4.1. Key Highlights
- 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
4.3. Global Precision Oncology Market Outlook: Type
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Mn) Analysis, By Type, 2019-2024
- 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2025-2032
  - 4.3.3.1. Therapeutics
  - 4.3.3.2. Diagnostics
- 4.3.4. Market Attractiveness Analysis: Type
4.4. Global Precision Oncology Market Outlook: Cancer Type
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Mn) Analysis, By Cancer Type, 2019-2024
- 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2025-2032
  - 4.4.3.1. Breast Cancer
  - 4.4.3.2. Lung Cancer
  - 4.4.3.3. Colorectal Cancer
  - 4.4.3.4. Prostate Cancer
  - 4.4.3.5. Skin Cancer
  - 4.4.3.6. Stomach Cancer
  - 4.4.3.7. Others
- 4.4.4. Market Attractiveness Analysis: Cancer Type
4.5. Global Precision Oncology Market Outlook: End User
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
- 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  - 4.5.3.1. Hospitals & Diagnostic Laboratories
  - 4.5.3.2. Pharmaceutical & Biotechnology Companies
  - 4.5.3.3. Research & Academic Institutes
  - 4.5.3.4. Others
- 4.5.4. Market Attractiveness Analysis: End User

5. Global Precision Oncology Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Precision Oncology Market Outlook:

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Type
- 6.2.3. By Cancer Type
- 6.2.4. By End User
6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2025-2032
- 6.4.1. Therapeutics
- 6.4.2. Diagnostics
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2025-2032
- 6.5.1. Breast Cancer
- 6.5.2. Lung Cancer
- 6.5.3. Colorectal Cancer
- 6.5.4. Prostate Cancer
- 6.5.5. Skin Cancer
- 6.5.6. Stomach Cancer
- 6.5.7. Others
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 6.6.1. Hospitals & Diagnostic Laboratories
- 6.6.2. Pharmaceutical & Biotechnology Companies
- 6.6.3. Research & Academic Institutes
- 6.6.4. Others
6.7. Market Attractiveness Analysis

7. Europe Precision Oncology Market Outlook:

7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Type
- 7.2.3. By Cancer Type
- 7.2.4. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2025-2032
- 7.4.1. Therapeutics
- 7.4.2. Diagnostics
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2025-2032
- 7.5.1. Breast Cancer
- 7.5.2. Lung Cancer
- 7.5.3. Colorectal Cancer
- 7.5.4. Prostate Cancer
- 7.5.5. Skin Cancer
- 7.5.6. Stomach Cancer
- 7.5.7. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 7.6.1. Hospitals & Diagnostic Laboratories
- 7.6.2. Pharmaceutical & Biotechnology Companies
- 7.6.3. Research & Academic Institutes
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. East Asia Precision Oncology Market Outlook:

8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Type
- 8.2.3. By Cancer Type
- 8.2.4. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2025-2032
- 8.4.1. Therapeutics
- 8.4.2. Diagnostics
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2025-2032
- 8.5.1. Breast Cancer
- 8.5.2. Lung Cancer
- 8.5.3. Colorectal Cancer
- 8.5.4. Prostate Cancer
- 8.5.5. Skin Cancer
- 8.5.6. Stomach Cancer
- 8.5.7. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 8.6.1. Hospitals & Diagnostic Laboratories
- 8.6.2. Pharmaceutical & Biotechnology Companies
- 8.6.3. Research & Academic Institutes
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. South Asia & Oceania Precision Oncology Market Outlook:

9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Type
- 9.2.3. By Cancer Type
- 9.2.4. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2025-2032
- 9.4.1. Therapeutics
- 9.4.2. Diagnostics
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2025-2032
- 9.5.1. Breast Cancer
- 9.5.2. Lung Cancer
- 9.5.3. Colorectal Cancer
- 9.5.4. Prostate Cancer
- 9.5.5. Skin Cancer
- 9.5.6. Stomach Cancer
- 9.5.7. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 9.6.1. Hospitals & Diagnostic Laboratories
- 9.6.2. Pharmaceutical & Biotechnology Companies
- 9.6.3. Research & Academic Institutes
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. Latin America Precision Oncology Market Outlook:

10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Type
- 10.2.3. By Cancer Type
- 10.2.4. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2025-2032
- 10.4.1. Therapeutics
- 10.4.2. Diagnostics
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2025-2032
- 10.5.1. Breast Cancer
- 10.5.2. Lung Cancer
- 10.5.3. Colorectal Cancer
- 10.5.4. Prostate Cancer
- 10.5.5. Skin Cancer
- 10.5.6. Stomach Cancer
- 10.5.7. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 10.6.1. Hospitals & Diagnostic Laboratories
- 10.6.2. Pharmaceutical & Biotechnology Companies
- 10.6.3. Research & Academic Institutes
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Middle East & Africa Precision Oncology Market Outlook:

11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Type
- 11.2.3. By Cancer Type
- 11.2.4. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2025-2032
- 11.4.1. Therapeutics
- 11.4.2. Diagnostics
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2025-2032
- 11.5.1. Breast Cancer
- 11.5.2. Lung Cancer
- 11.5.3. Colorectal Cancer
- 11.5.4. Prostate Cancer
- 11.5.5. Skin Cancer
- 11.5.6. Stomach Cancer
- 11.5.7. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 11.6.1. Hospitals & Diagnostic Laboratories
- 11.6.2. Pharmaceutical & Biotechnology Companies
- 11.6.3. Research & Academic Institutes
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Structure
- 12.1.1. Competition Intensity Mapping By Market
- 12.1.2. Competition Dashboard
12.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.2.1. Thermo Fisher Scientific Inc.
  - 12.2.1.1. Overview
  - 12.2.1.2. Segments and Types
  - 12.2.1.3. Key Financials
  - 12.2.1.4. Market Developments
  - 12.2.1.5. Market Strategy
- 12.2.2. Invitae Corporation
- 12.2.3. Qiagen N.V.
- 12.2.4. Illumina, Inc.
- 12.2.5. Laboratory Corporation Of America Holding
- 12.2.6. Exact Sciences Corporation
- 12.2.7. Rain Oncology Inc.
- 12.2.8. Strata Oncology, Inc.
- 12.2.9. Xilis, Inc.
- 12.2.10. Variantyx, Inc.
- 12.2.11. Bioserve
- 12.2.12. Relay Therapeutics
- 12.2.13. Acrivon Therapeutics
- 12.2.14. Foundation Medicine, Inc.
- 12.2.15. Others

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations

Precision Oncology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032